Nanoviricides Stock Performance
| NNVC Stock | USD 1.19 0.01 0.83% |
The company secures a Beta (Market Risk) of 0.49, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, NanoViricides' returns are expected to increase less than the market. However, during the bear market, the loss of holding NanoViricides is expected to be smaller as well. At this point, NanoViricides has a negative expected return of -0.0925%. Please make sure to verify NanoViricides' potential upside, as well as the relationship between the daily balance of power and market facilitation index , to decide if NanoViricides performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days NanoViricides has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, NanoViricides is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Last Split Factor 1:20 | Dividend Date 2019-09-24 | Last Split Date 2019-09-24 |
1 | NanoViricides to Present at the PODD 2025 Conference in Boston on October 27 | 10/27/2025 |
2 | NanoViricides Announces Pricing of 6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close | 11/11/2025 |
3 | NanoViricides Fiscal Q1 Earnings Snapshot | 11/14/2025 |
4 | NanoViricides GAAP EPS of -0.10 | 11/17/2025 |
5 | Will NanoViricides Inc. stock recover faster than industry - Weekly Risk Report Reliable Intraday Trade Alerts - newser.com | 11/19/2025 |
6 | NanoViricides Announces Pricing of 6 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Close - Lansing State Journal | 12/05/2025 |
7 | This AI Stock Has 45 percent Upside Potential and No One Is Talking About It Yet - Barchart.com | 12/11/2025 |
8 | NanoViricides initiated with a Buy at Alliance Global - TipRanks | 12/16/2025 |
| Begin Period Cash Flow | 4.8 M | |
| Total Cashflows From Investing Activities | -57 K |
NanoViricides | Build AI portfolio with NanoViricides Stock |
NanoViricides Relative Risk vs. Return Landscape
If you would invest 142.00 in NanoViricides on September 29, 2025 and sell it today you would lose (23.00) from holding NanoViricides or give up 16.2% of portfolio value over 90 days. NanoViricides is currently does not generate positive expected returns and assumes 6.2604% risk (volatility on return distribution) over the 90 days horizon. In different words, 56% of stocks are less volatile than NanoViricides, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
NanoViricides Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for NanoViricides' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as NanoViricides, and traders can use it to determine the average amount a NanoViricides' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0148
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | NNVC |
Based on monthly moving average NanoViricides is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NanoViricides by adding NanoViricides to a well-diversified portfolio.
NanoViricides Fundamentals Growth
NanoViricides Stock prices reflect investors' perceptions of the future prospects and financial health of NanoViricides, and NanoViricides fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on NanoViricides Stock performance.
| Return On Equity | -0.94 | ||||
| Return On Asset | -0.51 | ||||
| Current Valuation | 24.54 M | ||||
| Shares Outstanding | 21.57 M | ||||
| Price To Earning | (6.02) X | ||||
| Price To Book | 3.58 X | ||||
| EBITDA | (8.72 M) | ||||
| Net Income | (9.47 M) | ||||
| Cash And Equivalents | 14.07 M | ||||
| Cash Per Share | 1.21 X | ||||
| Total Debt | 1.31 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 34.92 X | ||||
| Book Value Per Share | 0.41 X | ||||
| Cash Flow From Operations | (8.48 M) | ||||
| Earnings Per Share | (0.50) X | ||||
| Market Capitalization | 25.67 M | ||||
| Total Asset | 8.82 M | ||||
| Retained Earnings | (148.84 M) | ||||
| Working Capital | 364.19 K | ||||
| Current Asset | 24.38 M | ||||
| Current Liabilities | 6.74 M | ||||
About NanoViricides Performance
By analyzing NanoViricides' fundamental ratios, stakeholders can gain valuable insights into NanoViricides' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if NanoViricides has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if NanoViricides has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.11) | (1.17) | |
| Return On Capital Employed | (1.28) | (1.34) | |
| Return On Assets | (1.07) | (1.13) | |
| Return On Equity | (1.26) | (1.32) |
Things to note about NanoViricides performance evaluation
Checking the ongoing alerts about NanoViricides for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for NanoViricides help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| NanoViricides generated a negative expected return over the last 90 days | |
| NanoViricides has high historical volatility and very poor performance | |
| NanoViricides may become a speculative penny stock | |
| NanoViricides has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (9.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NanoViricides currently holds about 14.07 M in cash with (8.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.21, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| NanoViricides has a frail financial position based on the latest SEC disclosures | |
| Latest headline from globenewswire.com: Anthem and Rencor Sign Costco to Springbanks Bingham Crossing Centre |
- Analyzing NanoViricides' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether NanoViricides' stock is overvalued or undervalued compared to its peers.
- Examining NanoViricides' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating NanoViricides' management team can have a significant impact on its success or failure. Reviewing the track record and experience of NanoViricides' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of NanoViricides' stock. These opinions can provide insight into NanoViricides' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for NanoViricides Stock analysis
When running NanoViricides' price analysis, check to measure NanoViricides' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoViricides is operating at the current time. Most of NanoViricides' value examination focuses on studying past and present price action to predict the probability of NanoViricides' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoViricides' price. Additionally, you may evaluate how the addition of NanoViricides to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |